FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964860713> ?p ?o ?g. }

• W1964860713 endingPage "26" @default.
• W1964860713 startingPage "11" @default.
• W1964860713 abstract "Cancer results from disturbances of cellular signal transduction and data processing at the genetic and epigenetic level. In the early phase of the disease these disturbances are mainly caused by environmental toxic agents, i.e. genotoxic and non-genotoxic carcinogens, whereas endogenous agents derived from dys-regulated metabolic reactions may take over this role at later stages, thereby leading to a state of 'genetic instability' and 'growth autonomy'. Among these metabolic reactions becoming dys-regulated in the course of tumorigenesis, eicosanoid biosynthesis from arachidonic acid seems to play a particular role. A steadily increasing body of evidence indicates a causal relationship between cancer development and an abnormal overexpression of eicosanoid-forming enzymes, i.e. cyclooxygenases and lipoxygenases, in a wide variety of human and animal tumors. This overexpression seems to result from disturbances of cellular signaling cascades such as the Ras-Raf-MAPkinase cascade due to oncogenic gene mutations. Presently, research is focussed on the proinflammatory enzyme cyclooxygenase-2 (COX-2) the pathological overexpression of which has been found to be related to key events of tumor promotion such as cellular hyperproliferation, inhibition of programmed cell death, and tumor angiogenesis. In the mouse skin model of multistage carcinogenesis COX-2-derived prostaglandin F(2alpha) has been indentified as an endogenous tumor promoter. Moreover, genotoxic byproducts of both cylooxygenase and lipoxygenase-catalyzed arachidonic acid metabolism (such as active oxygen species, free radicals etc.) are suspected to contribute to 'genetic instability' and thus to malignant progression of tumor cells. The enzymes of eicosanoid biosynthesis rank therefore among the most attractive targets for cancer chernoprevention. In fact, both nonsteroidal antiinflammatory drugs, i.e. non-specific COX inhibitors, and isozyme-specific COX-2 inhibitors have been shown to inhibit experimental and human cancer development, in the latter case in particular in the large bowel. Beside their role as indicators of neoplastic development eicosanoids may be also used as reporters of skin irritation. Based to this concept an in vitro test system for skin toxicity has been developed in which the release of arachidonic acid and interleukin-1alpha, i.e. two key mediators of acute inflammation, from a human keratinocyte cell line is measured. The excellent correlation found between this mediator release and the effects of various chemical irritants on human skin in vivo indicates that, in the near future, this and related methods may help to do without animal experiments in toxicological testing." @default.
• W1964860713 created "2016-06-24" @default.
• W1964860713 creator A5007487924 @default.
• W1964860713 creator A5011536112 @default.
• W1964860713 creator A5080601032 @default.
• W1964860713 date "2000-11-01" @default.
• W1964860713 modified "2023-09-23" @default.
• W1964860713 title "A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism" @default.
• W1964860713 cites W1504301934 @default.
• W1964860713 cites W1520258702 @default.
• W1964860713 cites W1527677525 @default.
• W1964860713 cites W1536570682 @default.
• W1964860713 cites W1555489233 @default.
• W1964860713 cites W1560539518 @default.
• W1964860713 cites W1562016580 @default.
• W1964860713 cites W1566737177 @default.
• W1964860713 cites W1597512265 @default.
• W1964860713 cites W1671834350 @default.
• W1964860713 cites W1784820495 @default.
• W1964860713 cites W1940826359 @default.
• W1964860713 cites W1972643373 @default.
• W1964860713 cites W1975683751 @default.
• W1964860713 cites W1977943300 @default.
• W1964860713 cites W1984367287 @default.
• W1964860713 cites W1987621344 @default.
• W1964860713 cites W1990499518 @default.
• W1964860713 cites W1990747124 @default.
• W1964860713 cites W1991735287 @default.
• W1964860713 cites W1996995529 @default.
• W1964860713 cites W1997364548 @default.
• W1964860713 cites W1998724709 @default.
• W1964860713 cites W2000912603 @default.
• W1964860713 cites W2002668908 @default.
• W1964860713 cites W2003350005 @default.
• W1964860713 cites W2003436829 @default.
• W1964860713 cites W2005674716 @default.
• W1964860713 cites W2006307451 @default.
• W1964860713 cites W2010355242 @default.
• W1964860713 cites W2015743692 @default.
• W1964860713 cites W2023595441 @default.
• W1964860713 cites W2024026951 @default.
• W1964860713 cites W2026897120 @default.
• W1964860713 cites W2026919347 @default.
• W1964860713 cites W2033052130 @default.
• W1964860713 cites W2033468796 @default.
• W1964860713 cites W2039249065 @default.
• W1964860713 cites W2041768024 @default.
• W1964860713 cites W2041860844 @default.
• W1964860713 cites W2041935246 @default.
• W1964860713 cites W2042029148 @default.
• W1964860713 cites W2043707891 @default.
• W1964860713 cites W2049573270 @default.
• W1964860713 cites W2050717908 @default.
• W1964860713 cites W2051686420 @default.
• W1964860713 cites W2062213512 @default.
• W1964860713 cites W2062719785 @default.
• W1964860713 cites W2070609164 @default.
• W1964860713 cites W2072094007 @default.
• W1964860713 cites W2074846736 @default.
• W1964860713 cites W2075115566 @default.
• W1964860713 cites W2076710572 @default.
• W1964860713 cites W2081324739 @default.
• W1964860713 cites W2091821996 @default.
• W1964860713 cites W2093531978 @default.
• W1964860713 cites W2095152292 @default.
• W1964860713 cites W2096952719 @default.
• W1964860713 cites W2107718611 @default.
• W1964860713 cites W2114437978 @default.
• W1964860713 cites W2139002144 @default.
• W1964860713 cites W2143199916 @default.
• W1964860713 cites W2146388445 @default.
• W1964860713 cites W2149752901 @default.
• W1964860713 cites W2152124429 @default.
• W1964860713 cites W2158444308 @default.
• W1964860713 cites W2190162356 @default.
• W1964860713 cites W2322606352 @default.
• W1964860713 cites W2331710171 @default.
• W1964860713 cites W2336169581 @default.
• W1964860713 doi "https://doi.org/10.1016/s0300-483x(00)00301-2" @default.
• W1964860713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11090944" @default.
• W1964860713 hasPublicationYear "2000" @default.
• W1964860713 type Work @default.
• W1964860713 sameAs 1964860713 @default.
• W1964860713 citedByCount "90" @default.
• W1964860713 countsByYear W19648607132012 @default.
• W1964860713 countsByYear W19648607132013 @default.
• W1964860713 countsByYear W19648607132014 @default.
• W1964860713 countsByYear W19648607132016 @default.
• W1964860713 countsByYear W19648607132017 @default.
• W1964860713 countsByYear W19648607132018 @default.
• W1964860713 countsByYear W19648607132020 @default.
• W1964860713 countsByYear W19648607132022 @default.
• W1964860713 crossrefType "journal-article" @default.
• W1964860713 hasAuthorship W1964860713A5007487924 @default.
• W1964860713 hasAuthorship W1964860713A5011536112 @default.
• W1964860713 hasAuthorship W1964860713A5080601032 @default.
• W1964860713 hasConcept C114246631 @default.
• W1964860713 hasConcept C121608353 @default.

• next